Literature DB >> 17513570

Rheumatoid arthritis in Dubai--delayed diagnosis and low usage of disease modifying antirheumatic drugs.

Humeira Badsha, K Ooi Kong, P P Tak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17513570      PMCID： PMC1954679          DOI： 10.1136/ard.2006.068171

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

1.  Reumatoid arthritis in Iraq.

Authors:  Z S Al Rawi; H A Al Shackarchi; N H Marjana; F D Hart
Journal:  Rheumatol Rehabil       Date:  1977-05

2.  Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration.

Authors:  J J Anderson; G Wells; A C Verhoeven; D T Felson
Journal:  Arthritis Rheum       Date:  2000-01

3.  Rheumatoid arthritis in a population sample in the Gulf: clinical observations.

Authors:  H M al Attia; O B Gatee; S George; M M Masri
Journal:  Clin Rheumatol       Date:  1993-12       Impact factor: 2.980

Review 4.  Efficacy, tolerability and cost effectiveness of disease-modifying antirheumatic drugs and biologic agents in rheumatoid arthritis.

Authors:  Michael T Nurmohamed; Ben A C Dijkmans
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year.

Authors:  Suzan M M Verstappen; Johannes W G Jacobs; Johannes W J Bijlsma; Anton H M Heurkens; Christina van Booma-Frankfort; Evert Jan ter Borg; Dick M Hofman; Maaike J van der Veen
Journal:  Arthritis Rheum       Date:  2003-07

6.  The expression of rheumatoid arthritis in Kuwaiti patients in an outpatient hospital-based practice.

Authors:  I H Al-Salem; A M Al-Awadhi
Journal:  Med Princ Pract       Date:  2004 Jan-Feb       Impact factor: 1.927

7.  The expression of rheumatoid arthritis in Saudi Arabia.

Authors:  S R Alballa
Journal:  Clin Rheumatol       Date:  1995-11       Impact factor: 2.980
  7 in total
  7 in total

1.  The benefits of yoga for rheumatoid arthritis: results of a preliminary, structured 8-week program.

Authors:  Humeira Badsha; Vishwas Chhabra; Cathy Leibman; Ayman Mofti; Kok Ooi Kong
Journal:  Rheumatol Int       Date:  2009-01-31       Impact factor: 2.631

2.  Rheumatoid arthritis in the United Arab Emirates.

Authors:  Humeira Badsha; Kok Ooi Kong; Paul P Tak
Journal:  Clin Rheumatol       Date:  2007-11-01       Impact factor: 2.980

3.  Lag time between onset of symptoms and diagnosis in Venezuelan patients with rheumatoid arthritis.

Authors:  Elaudi Rodríguez-Polanco; Soham Al Snih; Yong-Fang Kuo; Alberto Millán; Martín A Rodríguez
Journal:  Rheumatol Int       Date:  2010-01-12       Impact factor: 2.631

4.  Safety, Tolerability, and Efficacy of Tocilizumab in Rheumatoid Arthritis: An Open-Label Phase 4 Study in Patients from the Middle East.

Authors:  Mohammed Hammoudeh; Adel Al Awadhi; Eman Haji Hasan; Maassoumeh Akhlaghi; Arman Ahmadzadeh; Bahar Sadeghi Abdollahi
Journal:  Int J Rheumatol       Date:  2015-05-19

Review 5.  Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs.

Authors:  Tuulikki Sokka; Minja Envalds; Theodore Pincus
Journal:  Mod Rheumatol       Date:  2008-04-25       Impact factor: 3.023

6.  Diagnostic delay in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: results from the Danish nationwide DANBIO registry.

Authors:  Jan Sørensen; Merete Lund Hetland
Journal:  Ann Rheum Dis       Date:  2014-02-17       Impact factor: 19.103

7.  Diagnostic Delay in Patients with Primary Sjögren's Syndrome: A Population-Based Cohort Study in Taiwan.

Authors:  Yu-Tung Huang; Tsung-Hsueh Lu; Pi-Ling Chou; Meng-Yu Weng
Journal:  Healthcare (Basel)       Date:  2021-03-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.